TI
CRMD icon

Trexquant Investment’s CorMedix CRMD Stock Holding History

Trexquant Investment’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.9M Buy
623,797
+63,160
+11% +$499K 0.03% 759
2026
Q1 		$3.81M Buy
+560,637
New +$4.14M 0.03% 763
2025
Q4 		– Sell
-258,002
Closed -$3M – 1633
2025
Q3 		$3M Sell
258,002
-449,957
-64% -$5.44M 0.03% 746
2025
Q2 		$8.72M Buy
707,959
+572,472
+423% +$6.32M 0.1% 299
2025
Q1 		$835K Buy
135,487
+115,819
+589% +$1.2M 0.01% 1144
2024
Q4 		$159K Buy
+19,668
New +$196K ﹤0.01% 1490

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Trexquant Investment's CRMD Position: Q2 2026 in Review

Trexquant Investment increased its CorMedix (CRMD) stake by 11% in Q2 2026, buying an estimated $499K and bringing the position to 623,797 shares worth $4.9M. The position accounts for 0.03% of the portfolio, ranked #759.

Trexquant Investment first reported a position in CRMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.72M in Q2 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Trexquant Investment held 623,797 shares of CorMedix worth $4.9M as of Q2 2026.
  • Trexquant Investment bought 63,160 CorMedix shares in Q2 2026, an estimated $499K.
  • CorMedix made up 0.03% of Trexquant Investment's portfolio in Q2 2026, its #759 holding.
  • Trexquant Investment first reported a position in CorMedix in Q4 2024 and has held it in 6 quarters since.
  • Trexquant Investment's CorMedix position peaked at $8.72M in Q2 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.